Medicare Enrolled

Dr. Rachel Osborn, MD

Q: Does Dr. Osborn receive payments from pharmaceutical companies?

Yes. Dr. Osborn received a total of $5,195 from 50 companies across 326 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently High for Dr. Osborn) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Obstetrics & Gynecology · Flower Mound, TX

3051 CHURCHILL DR STE 220, Flower Mound, TX 75022

2145131101

Registered in NPPES since 2009

NPI: 1578793311 verify on NPPES ↗

High

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Osborn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Osborn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Osborn

Dr. Rachel Osborn is an obstetrics & gynecology specialist in Flower Mound, TX, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Osborn received a total of $5,195 from 50 pharmaceutical and/or device companies across 326 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Osborn is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration $5,195 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$5,195

Total received (2018-2024)

Avg $742/year across 7 years

Top 14% in TX for obstetrics & gynecology

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

326

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$839

2023

$918

2022

$826

2021

$877

2020

$643

2019

$359

2018

$732

Payments by company (2024)

SHIELD THERAPEUTICS INC

$156

Astellas Pharma US Inc

$153

MILLICENT US INC

$128

MAYNE PHARMA COMMERCIAL LLC

$80

Organon Llc

$71

PFIZER INC.

$63

Biogen, Inc.

$57

IDORSIA PHARMACEUTICALS US INC

$39

Currax Pharmaceuticals LLC

$31

ABBVIE INC.

$19

Exeltis, USA Inc.

$17

Agile Therapeutics, Inc.

$15

Mission Pharmacal Company

Top 3 companies account for 52.2% of 2024 payments

All-time payments by company (2018-2024) ›

ABBVIE INC.

$495

Currax Pharmaceuticals LLC

$455

Astellas Pharma US Inc

$401

AbbVie Inc.

$393

PFIZER INC.

$282

Roche Diagnostics Corporation

$244

MILLICENT US INC

$230

AbbVie, Inc.

$199

MAYNE PHARMA INC.

$193

Allergan Inc.

$188

SHIELD THERAPEUTICS INC

$156

MAYNE PHARMA COMMERCIAL LLC

$132

Endo Pharmaceuticals Inc.

$131

Organon LLC

$122

Novo Nordisk Inc

$115

VIVUS, Inc.

$112

TherapeuticsMD, Inc.

$89

Exeltis, USA Inc.

$76

Organon Llc

$71

IDORSIA PHARMACEUTICALS US INC

$71

Avion Pharmaceuticals

$69

AMAG Pharmaceuticals, Inc.

$68

CooperSurgical, Inc.

$67

Allergan, Inc.

$67

Sumitomo Pharma America, Inc.

$62

Virtus Pharmaceuticals LLC

$60

Biogen, Inc.

$57

Agile Therapeutics, Inc.

$47

Duchesnay USA Incorporated

$44

Merck Sharp & Dohme Corporation

$41

Myriad Women's Health, Inc.

$36

Bayer HealthCare Pharmaceuticals Inc.

$35

Avanos Medical

$33

Mylan Pharmaceuticals Inc.

$32

Takeda Pharmaceuticals U.S.A., Inc.

$31

Evofem Biosciences, Inc.

$29

Salix Pharmaceuticals, a division of Bausch Health US, LLC

$27

Nalpropion Pharmaceuticals, Inc.

$27

Lupin Inc.

$24

Shield Therapeutics Inc

$23

Hologic, LLC

$23

Bayer Healthcare Pharmaceuticals Inc.

$20

Mycovia Pharmaceuticals, Inc.

$20

VIVUS LLC

$18

Boston Scientific Corporation

$17

Merck Sharp & Dohme LLC

$14

Eisai Inc.

$14

EISAI INC.

$13

Orexigen Therapeutics, Inc.

$11

Mission Pharmacal Company

Top 3 companies account for 26.0% of all-time payments

Associated products mentioned in payments ›

ACCRUFER · ANNOVERA · BELSOMRA · BIJUVA · Balcoltra · Belviq · CITRANATAL MEDLEY · CONTRAVE · Divigel · FEMRING · Femring · IMVEXXY · INTRAROSA · JADA SYSTEM · Kyleena · LILETTA · LO LOESTRIN FE · Lupron · MAKENA · MYFEMBREE · MYRISK · Mirena · Myrbetriq · NASCOBAL · NEXPLANON · Novasure · ON-Q* PUMP AND ACCESSORIES · ONZETRA XSAIL · ORIAHNN · ORILISSA · Orilissa · Osphena · PREMARIN · PREMARIN ORALS · PROMETRIUM · Paragard · Phexxi · QSYMIA · QUVIVIQ · Qsymia · RS Harmony Test Related Products · SLYND · SOLOSEC · SYMPHION · Saxenda · Trintellix · Twirla · VUMERITY · Veozah · Vitafol Ultra · Vivjoa · Wegovy · XIFAXAN · Xulane

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for an obstetrics & gynecology specialist in Flower Mound?
Compare obstetricians & gynecologists in the Flower Mound area by procedure volume, costs, and industry payment transparency.

Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists in nearby ZIP areas

679

County median income

$108,185

Nearest hospital to ZIP centroid (approximate)

TEXAS HEALTH PRESBYTERIAN HOSPITAL FLOWER MOUND
3.2 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Osborn is an obstetrics & gynecology specialist, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Osborn receive payments from pharmaceutical companies?

Yes. Dr. Osborn received a total of $5,195 from 50 companies across 326 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently High for Dr. Osborn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Obstetricians & Gynecologists in Flower Mound

Browse obstetricians & gynecologists in Flower Mound ranked by procedure volume and transparency data.

Highest volume

Top Obstetricians & Gynecologists in TX

Obstetricians & gynecologists ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Obstetricians & Gynecologists in TX

Which TX obstetricians & gynecologists receive the most from drug and device companies.

By company

ABBVIE INC. Payments to Doctors

See all physicians who received payments from ABBVIE INC.

By company

Currax Pharmaceuticals LLC Payments to Doctors

See all physicians who received payments from Currax Pharmaceuticals LLC.

By company

Astellas Pharma US Inc Payments to Doctors

See all physicians who received payments from Astellas Pharma US Inc.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology